✦ Where quality meets affordability · Biomed-tested · Certified

Dexcom lifts 2026 revenue outlook after positive Q3

Dexcom lifts 2026 revenue outlook after positive Q3
Summary

Dexcom now expects 2026 revenues to land in the $5.2bn to $5.25bn range, up from $5.18bn at the low-end as previously outlined.

The post Dexcom lifts 2026 revenue outlook after positive Q3 appeared first on Medical Device Network.

Read the full article ↗Looking to buy or rent? Get a quote

More from Medical Device Network

Omron Healthcare begins production at first India plantJ&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3Abbott’s paravalvular leak treatment secures FDA approvalBaxter’s shares fall as Q3 probability dips despite revenue growth